Disappointment for Australian company Actinogen Medical (ASX:ACW) with the release of data from its phase 2 clinical trial (XanADu) investigating its investigative therapy Xanamem in patients with mild dementia due to Alzheimer’s disease. …
Latest Video
New Stories
-
Daily updates on COVID-19 vaccine - 25 June 2021
June 25, 2021 - - COVID-19 -
Opal Biosciences seeking partners to establish precinct
June 25, 2021 - - Latest News -
Liberal chaired committee tells Greg Hunt to try again
June 25, 2021 - - Latest News -
New Zealand's epilepsy patients facing another forced switch
June 25, 2021 - -
What are these 'decision parameters'?
June 25, 2021 - - Latest News -
Chemist Warehouse opens second European store
June 24, 2021 - - Latest News -
Private insurers launch campaign promoting reform of device pricing
June 24, 2021 - - Other Health